Page last updated: 2024-12-06

marrubiin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Marrubiin is a diterpenoid compound found in the plant *Marrubium vulgare*, commonly known as horehound. It has been studied for its various biological effects, including anti-inflammatory, antiviral, and anti-cancer activities. Marrubiin's complex structure has made its synthesis challenging, and several synthetic routes have been investigated. The compound's potential therapeutic benefits have led to ongoing research into its mechanisms of action and its potential for drug development. Marrubiin's anti-inflammatory properties, specifically its inhibition of TNF-alpha production, are particularly interesting for its potential use in treating inflammatory diseases. The compound's antiviral activity against several viruses, including the influenza virus and the herpes simplex virus, has also garnered significant attention. Furthermore, marrubiin's potential as an anti-cancer agent has been explored, showing promising results in inhibiting the growth of certain cancer cells. Marrubiin's unique structure and its diverse biological activities have made it a subject of continued research, exploring its potential applications in medicine and pharmaceutical development.'

marrubiin: RN given for (2aS-(2aalpha,5abeta,6alpha,7alpha,8aalpha,8balpha))-isomer; often isolated from MARRUBIUM. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID73401
CHEMBL ID1999372
CHEBI ID6696
SCHEMBL ID2784576
MeSH IDM0275712

Synonyms (27)

Synonym
ap086p88m4 ,
unii-ap086p88m4
nsc 36693
2h-naphtho(1,8-bc)furan-2-one, 6-(2-(3-furanyl)ethyl)decahydro-6-hydroxy-2a,5a,7-trimethyl-, (2as-(2aalpha,5abeta,6alpha,7alpha,8aalpha,8balpha))-
marrubin
8.beta.h-labda-13(16), 15,16-epoxy-6.beta.,9-dihydroxy-, .gamma.-lactone
2h-naphtho[1, 6-[2-(3-furanyl)ethyl]decahydro-6-hydroxy-2a,5a,7-trimethyl-, [2as-(2a.alpha.,5a.beta.,6.alpha.,7.alpha.,8a.alpha.,8b.alpha.)]-
nsc-36693
465-92-9
marrubiin
C09128
2h-naphtho[1,8-bc]furan-2-one,6-[2-(3-furanyl)ethyl]decahydro-6-hydroxy-2a,5a,7-trimethyl-,(2as,5as,6r,7r,8ar,8br)-
marrubiin [mi]
(2as,5as,6r,7r,8ar,8br)-6-(2-(3-furanyl)ethyl)decahydro-6-hydroxy-2a,5a,7-trimethyl-2h-naphtho(1,8-bc)furan-2-one
SCHEMBL2784576
CHEBI:6696 ,
CHEMBL1999372
mfcd08461003
marrubium bitter
Q11770828
DTXSID50963595
CS-0101468
MS-25009
HY-N6995
(1r,4s,8s,9r,10r,12r)-9-[2-(furan-3-yl)ethyl]-9-hydroxy-4,8,10-trimethyl-2-oxatricyclo[6.3.1.04,12]dodecan-3-one
XM36381
AKOS040760545

Research Excerpts

Treatment

ExcerptReferenceRelevance
"Treatment with marrubiin effectively improved lesion regression and inhibited toxicity in the mouse model of endometriosis."( Protective effects of marrubiin improve endometriosis through suppression of the expression of RANTES.
Sun, XH, 2017
)
1.11

Bioavailability

ExcerptReferenceRelevance
" Herein, we aimed to formulate marrubiin loaded solid lipid nanoparticles (SLNs) to improve its pharmacokinetics and bioavailability and also to investigate free drug and formulation's protective impact against intracellular reactive oxygen species (ROS) generation in HUVECs."( Marrubiin-loaded solid lipid nanoparticles' impact on TNF-α treated umbilical vein endothelial cells: A study for cardioprotective effect.
Barar, J; Eskandani, M; Garjani, A; Ghafari, S; Nakhlband, A; Omidi, Y; Saeedi, N, 2018
)
2.21
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
gamma-lactoneA lactone having a five-membered lactone ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (26)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (7.69)18.2507
2000's5 (19.23)29.6817
2010's14 (53.85)24.3611
2020's5 (19.23)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 30.20

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index30.20 (24.57)
Research Supply Index3.30 (2.92)
Research Growth Index5.14 (4.65)
Search Engine Demand Index36.71 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (30.20)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (7.69%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other24 (92.31%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]